Citation: A. Heider et al., BENDAMUSTIN - RELAPSE THERAPY IN PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL), European journal of cancer, 33, 1997, pp. 1219-1219
Citation: A. Heider et al., BENDAMUSTIN AS 2ND-LINE THERAPY IN PATIEN TS WITH RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA AND MULTIPLE-MYELOMA, Tumordiagnostik & Therapie, 18(3), 1997, pp. 71-75
Authors:
HEIDER A
SANTIBANEZ S
TISCHER A
GERIKE E
TIKHONOVA N
IGNATYEV G
MRAZOVA M
ENDERS G
SCHREIER E
Citation: A. Heider et al., COMPARATIVE INVESTIGATION OF THE LONG NONCODING M-F GENOME REGION OF WILD-TYPE AND VACCINE MEASLES VIRUSES, Archives of virology, 142(12), 1997, pp. 2521-2528
Authors:
VONPAWEL J
WAGNER H
NIEDERLE N
HEIDER A
KOSCHEL G
HECKER D
HANSKE M
Citation: J. Vonpawel et al., PHASE-II STUDY OF PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 47-50
Authors:
VONPAWEL J
WAGNER H
NIEDERLE N
HEIDER A
KOSCHEL G
GROMOTKA E
HANSKE M
Citation: J. Vonpawel et al., PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER -RESULTS OF A PHASE-II TRIAL, Seminars in oncology, 23(5), 1996, pp. 7-9
Citation: B. Weidmann et al., 5-FLUOROURACIL CARDIOTOXICITY WITH LEFT-VENTRICULAR DYSFUNCTION UNDERDIFFERENT DOSING REGIMENS, The American journal of cardiology, 75(2), 1995, pp. 194-195